ClinicalTrials.gg
Not yet recruitingNCT06371183Updated Jul 16, 2024

A Comparative Study of Clinical, Endoscopic and Histopathological Features of Colitis in Children

An interventional study of Colonoscope in Role of Ileoscopy in Diagnosis of Colitis, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Month to 18 Years. Per ClinicalTrials.gov, last updated 2024-07-16.

Sponsored by Assiut University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
196
Allocation
Not applicable
Ages
1 Month to 18 Years
Sex
All
01

Study summary

A Comparative study of clinical, endoscopic and histopathological features of colitis in children

Read the detailed description

To find out the role of ileoscopy in diagnosis of colitis and compare clinical , endoscopic and histopathological manifestations of colitis

02

Conditions studied

  • Role of Ileoscopy in Diagnosis of Colitis
03

In context

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. All patients diagnosed as colitis during the study period. 2. Age from 1 month to 18 years.

Exclusion criteria

Exclusion Criteria:

  1. Patients with lower gastrointestinal manifestations and weren't diagnosed as colitis during colonoscope.
  2. Patients less than one month and more than 18 years.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
196 participants (estimated)

Study arms

  • Other
    Patients with lower GI manifestations

    Patients with lower GI manifestations will undergo total colonoscopy with biopsy

    Device: Colonoscope

Interventions

  • DeviceColonoscope

    Endoscopy for lower GIT

06

What researchers measure

Primary outcomes

  1. Is ileoscopy indicated for all children complaining of colitis on 196 patient

    Biopsy from ileum will be taken to diagnose colitis

    Time frame: 2years

Secondary outcomes

  1. To correlate clinical manifestations by colonoscopic picture

    Some patients with lower GI manifestations,their colonoscopy is normal. So corolate clinical with biopsy

    Time frame: 2years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — I will share the IPD results

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06371183
Lead sponsor
Assiut University
Responsible party
Asmaa Omar Mahmoud Said (AOMSaid, Assiut University) — Principal investigator
First posted
Apr 17, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Aug 30, 2026 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Jul 16, 2024

Study contacts

Asmaa Omar, MD
Contact
asmaaomar2749@gmail.com
01003337028
Nagla Hassan Abufadan, Prof
Contact
nagla.ibrahim@med.au.edu.eg
0111 187 2237

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion